Table 2: Clinical outcomes from Schulte-Kemna_2015 used for exploratory analysis.

Outcome

Revascularization Group (n = 52)

Conservative (Medical) Group (n = 33)

Between-Group Difference / Notes

Antihypertensive Drugs (mean #)

↓ by 0.76

↑ by 0.47

Significant reduction vs increase (p < 0.0001)

Blood Pressure (mmHg)

↓ from 154/78 → 140/73

↓ from 159/74 → 150/80

Greater BP reduction with revascularization

Hospitalization for Heart Failure (%)

13.60%

38.50%

Significantly lower with revascularization (p = 0.016)

Mortality (%)

10%

39.40%

Significantly lower with revascularization (p = 0.041)

Serum Creatinine (mg/dL)

↓ from 2.2 → 1.8

~ 2.0 → 2.0 (no change)

Trend toward improvement only in revascularization group